London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
According to an official statement issued by AstraZeneca, "The FDA has
"The FDA has authorised the restart in the US, following the resumption of trials in other countries in recent weeks. The FDA reviewed all safety data from trials globally and concluded it was safe to resume the trial."
Related News
AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early...
San Francisco Chronicle 2020-10-23AstraZeneca May Resume COVID-19 Vaccine Trial in U.S. This Week
As the draft of a form letter to UK AstraZeneca vaccine trial participants states, FDA “has come to the same conclusion as the other drug regulators including the MHRA” and...
Coinspeaker 2020-10-21COVID-19 Vaccine Volunteer in Brazil’s AstraZeneca Trial Dies, AZN Stock Plummets 1%
It is unclear whether the volunteer took the vaccine dose or was in a placebo group. AstraZeneca has not provided much information but said they followed all required...
Coinspeaker 2020-10-22Coronavirus vaccine volunteer in Brazil's AstraZeneca trial dies -- but authorities say trial to continue
A volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died, the Brazilian health agency Anvisa announced on Wednesday. Yet the trial is set to...
Beatrice Daily Sun
2020-10-22